- 相關(guān)推薦
子宮內(nèi)膜異位癥sICAM
【關(guān)鍵詞】 子宮內(nèi)膜異位癥Changes of sICAM1 and sHLAⅠin endometriosis and its significance
【Abstract】 AIM: To investigate the relationship between endometriosis (EMs) and the levels of soluble intercellular adhesion molecule1 (sICAM1) and soluble human leucocyte antigen1 (sHLAⅠ). METHODS: Thirty serum and 30 peritoneal fluid (PF) of patients with EMs (test group) and 30 serum and 30 peritoneal fluid of patients without EMs (control group) were studied. The levels of sICAM1 and sHLAⅠwere detected by enzymelinked immunosorbent assay (ELISA). RESULTS: ① Significantly higher levels of sICAM1 in serum and PF were observed in patients with EMs compared with those in controls (P0.05). ② The levels of sICAM1 in serum and PF were significantly different and the levels in earlystage EMs group were higher than those in advanced group (P0.05). ③ Serum sHLAⅠ cevel was lower in EMs group (P0.05) but the level in earlystage EMs group was higher than that in advanced group (P0.05). ④ There were no statistically significant differences in the levels of sHLAⅠin PF between the patients and the controls (P0.05). CONCLUSION: Changes of sICAM1and sHLAⅠmay play a role in the genesis of endometriosis.
【Keywords】 endometriosis; HLA antigens; intercellular adhesion molecule1; enzymelinked immunosorbent assay
【摘要】 目的： 探討盆腔子宮內(nèi)膜異位癥（內(nèi)異癥）患者血清和腹腔液中可溶性細(xì)胞間粘附分子1(sICAM1)、可溶性人類(lèi)白細(xì)胞抗原Ⅰ(sHLAⅠ)的水平與該病的發(fā)病關(guān)系. 方法： 以ELISA法定量檢測(cè)sICAM1的水平、半定量檢測(cè)sHLAⅠ水平. 結(jié)果： 內(nèi)異癥組血清和腹腔液中sICAM1和sHLAⅠ水平明顯高于對(duì)照組(P
【子宮內(nèi)膜異位癥sICAM】相關(guān)文章：
核因子κB在子宮內(nèi)膜異位癥中的表達(dá)和意義03-08
腹腔鏡下子宮肌瘤剔除術(shù)與開(kāi)腹子宮肌瘤剔除術(shù)的比較03-16
166例子宮肌瘤臨床分析03-16
頸動(dòng)脈內(nèi)膜—中層厚度的超聲評(píng)價(jià)與冠心病相關(guān)性研究03-29
腹腔鏡輔助陰式子宮切除術(shù)03-18
反義CD151基因抑制血管損傷后內(nèi)膜增生的實(shí)驗(yàn)研究03-08